| Date Filed | Type | Description |
| 05/26/2023 |
4
| Torti Frank (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 55,000 options to buy
@ $0 |
|
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2022 |
4
| Torti Frank (Director) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Granted 100,126 shares
@ $0
Granted 329,485 options to buy
@ $7.94, valued at
$2.6M
|
|
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2020 |
4
| Torti Frank (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 22,000 options
@ $0 |
|
| 05/18/2020 |
4
| Torti Frank (Director) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Granted 28,400 shares
@ $0
Granted 42,600 options to buy
@ $19.01, valued at
$809.8k
|
|
| 04/17/2020 |
4
| Torti Frank (Director) has filed a Form 4 on Axovant Gene Therapies Ltd.|
Txns:
| Granted 17,500 options to buy
@ $3.45, valued at
$60.4k
|
|
| 12/20/2019 |
4
| Torti Frank (Director) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Granted 137,617 options to buy
@ $7.86, valued at
$1.1M
Granted 893 options to buy
@ $7.86, valued at
$7k
Granted 11,488 options to buy
@ $8.43, valued at
$96.8k
Granted 3,765 options to buy
@ $8.43, valued at
$31.7k
|
|
| 12/20/2019 |
3
| Torti Frank (Director) has filed a Form 3 on Immunovant, Inc. |
| 08/27/2019 |
4
| Torti Frank (Director) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 58,608 options to buy
@ $7.65, valued at
$448.4k
|
|
| 08/20/2019 |
4
| Torti Frank (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 22,000 options
@ $0 |
|
| 07/11/2019 |
4
| Torti Frank (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 25,000 options to buy
@ $8.78, valued at
$219.5k
|
|
| 04/17/2019 |
4
| Torti Frank (Director) has filed a Form 4 on Axovant Sciences Ltd.|
Txns:
| Granted 255,000 options to buy
@ $1.06, valued at
$270.3k
|
|
| 11/27/2018 |
4
| Torti Frank (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 44,000 options to buy
@ $4.72, valued at
$207.7k
|
|
| 11/27/2018 |
3
| Torti Frank (Director) has filed a Form 3 on Arbutus Biopharma Corp |
| 11/26/2018 |
4
| Torti Frank (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 50,000 options to buy
@ $8.01, valued at
$400.5k
|
|
| 11/08/2018 |
4
| Torti Frank (Director) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 45,000 options to buy
@ $22.83, valued at
$1M
|
|
| 11/08/2018 |
3
| Torti Frank (Director) has filed a Form 3 on Myovant Sciences Ltd. |
| 10/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/26/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |